Characterization of the Menin-MLL Interaction as Therapeutic Cancer Target

zu Verbundenen Objekten

Standort
Deutsche Nationalbibliothek Frankfurt am Main
Umfang
Online-Ressource
Sprache
Englisch

Erschienen in
In: Cancers 12.2020, 1 Article 201

Ereignis
Veröffentlichung
(wo)
Furtwangen
(wer)
Hochschule Furtwangen
(wann)
2020
Urheber
Brzezinka, Krzysztof
Nevedomskaya, Ekaterina
Lesche, Ralf
Haegebarth, Andrea
Laak, Antonius ter
Fernandez-Montalvan, Amaury E.
Eberspächer, Uwe
Werbeck, Nicolas
Moenning, Ursula
Siegel, Stephan
Haendler, Bernard
Eheim, Ashley L.
Stresemann, Carlo

DOI
10.3390/cancers12010201
URN
urn:nbn:de:bsz:fn1-opus4-71459
Rechteinformation
Der Zugriff auf das Objekt ist unbeschränkt möglich.
Letzte Aktualisierung
15.08.2025, 07:25 MESZ

Datenpartner

Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Original beim Datenpartner anzeigen

Beteiligte

  • Brzezinka, Krzysztof
  • Nevedomskaya, Ekaterina
  • Lesche, Ralf
  • Haegebarth, Andrea
  • Laak, Antonius ter
  • Fernandez-Montalvan, Amaury E.
  • Eberspächer, Uwe
  • Werbeck, Nicolas
  • Moenning, Ursula
  • Siegel, Stephan
  • Haendler, Bernard
  • Eheim, Ashley L.
  • Stresemann, Carlo
  • Hochschule Furtwangen

Entstanden

  • 2020

Ähnliche Objekte (12)

Co-inhibition of HDAC and MLL-menin interaction targets MLL-rearranged acute myeloid leukemia cells via disruption of DNA damage checkpoint and DNA repair

Co-inhibition of HDAC and MLL-menin interaction targets MLL-rearranged acute myeloid leukemia cells via disruption of DNA damage checkpoint and DNA repair

Combined targeting of the Menin-MLL chromatin regulatory complex and the FLT3 tyrosine kinase as a novel therapeutic approach against NPM1mut and MLL-r leukemia with concurrent FLT3 mutation

Combined targeting of the Menin-MLL chromatin regulatory complex and the FLT3 tyrosine kinase as a novel therapeutic approach against NPM1mut and MLL-r leukemia with concurrent FLT3 mutation

SET-PP2A complex as a new therapeutic target in KMT2A (MLL) rearranged AML

SET-PP2A complex as a new therapeutic target in KMT2A (MLL) rearranged AML

Multi-omics analyses of MEN1 missense mutations identify disruption of menin–MLL and menin–JunD interactions as critical requirements for molecular pathogenicity

Multi-omics analyses of MEN1 missense mutations identify disruption of menin–MLL and menin–JunD interactions as critical requirements for molecular pathogenicity

Multi-omics analyses of MEN1 missense mutations identify disruption of menin–MLL and menin–JunD interactions as critical requirements for molecular pathogenicity

Multi-omics analyses of MEN1 missense mutations identify disruption of menin–MLL and menin–JunD interactions as critical requirements for molecular pathogenicity

NG2 antigen is a therapeutic target for MLL-rearranged B-cell acute lymphoblastic leukemia

NG2 antigen is a therapeutic target for MLL-rearranged B-cell acute lymphoblastic leukemia

Therapeutic strategies against hDOT1L as a potential drug target in MLL-rearranged leukemias

Therapeutic strategies against hDOT1L as a potential drug target in MLL-rearranged leukemias

Multi-omics analyses of MEN1 missense mutations identify disruption of menin-MLL and menin-JunD interactions as critical requirements for molecular pathogenicity : : LBODP106

Multi-omics analyses of MEN1 missense mutations identify disruption of menin-MLL and menin-JunD interactions as critical requirements for molecular pathogenicity : : LBODP106

Menin

Kapitel

Menin

The epigenetic regulators EP300/CREBBP represent promising therapeutic targets in MLL-rearranged acute myeloid leukemia

The epigenetic regulators EP300/CREBBP represent promising therapeutic targets in MLL-rearranged acute myeloid leukemia

"Menin, Marktplatz."

Fotos

"Menin, Marktplatz."

Menin Panorama

Ansichtskarte / Motivkarte | Postkarte

Menin Panorama

Verbundene Objekte